Cargando…

Requirement for Interaction of PI3-Kinase p110α with RAS in Lung Tumor Maintenance

RAS proteins directly activate PI3-kinases. Mice bearing a germline mutation in the RAS binding domain of the p110α subunit of PI3-kinse are resistant to the development of RAS-driven tumors. However, it is unknown whether interaction of RAS with PI3-kinase is required in established tumors. The nee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castellano, Esther, Sheridan, Clare, Thin, May Zaw, Nye, Emma, Spencer-Dene, Bradley, Diefenbacher, Markus E., Moore, Christopher, Kumar, Madhu S., Murillo, Miguel M., Grönroos, Eva, Lassailly, Francois, Stamp, Gordon, Downward, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826036/ https://www.ncbi.nlm.nih.gov/pubmed/24229709 http://dx.doi.org/10.1016/j.ccr.2013.09.012

Ejemplares similares

Disruption of the Interaction of RAS with PI 3-Kinase Induces Regression of EGFR-Mutant-Driven Lung Cancer
por: Murillo, Miguel M., et al.
Publicado: (2018)

RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
por: Fritsch, Ralph, et al.
Publicado: (2013)

JunD, not c-Jun, is the AP-1 transcription factor required for Ras-induced lung cancer
por: Ruiz, E. Josue, et al.
Publicado: (2021)

YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK–STAT3 Signaling
por: Gruber, Ralph, et al.
Publicado: (2016)

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
por: Coelho, Matthew A., et al.
Publicado: (2017)

RAS signalling through PI3-Kinase controls cell migration via modulation of Reelin expression
por: Castellano, Esther, et al.
Publicado: (2016)

YAP drives cutaneous squamous cell carcinoma formation and progression
por: Vincent-Mistiaen, Zoé, et al.
Publicado: (2018)

The Importance of Being PI3K in the RAS Signaling Network
por: Cuesta, Cristina, et al.
Publicado: (2021)

Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110α
por: Ismail, Mohamed, et al.
Publicado: (2023)

Duct- and Acinar-Derived Pancreatic Ductal Adenocarcinomas Show Distinct Tumor Progression and Marker Expression
por: Ferreira, Rute M.M., et al.
Publicado: (2017)

SUN-110 The Role Of RasD2 In Metabolism And Obesity
por: Fong, Vincent, et al.
Publicado: (2019)

Drugging the Undruggable: Advances on RAS Targeting in Cancer
por: Molina-Arcas, Miriam, et al.
Publicado: (2021)

FBXW7 mutations typically found in human cancers are distinct from null alleles and disrupt lung development
por: Davis, Hayley, et al.
Publicado: (2011)

RAC1(P29S) Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance
por: Lionarons, Daniël A., et al.
Publicado: (2019)

$\pi$p->$\pi$ $\pi$ N reactions near threshold-80-110
por: CERN. Geneva. Proton Synchrotron and Synchrocyclotron Committee
Publicado: (1980)

Intermolecular biparatopic trapping of ErbB2 prevents compensatory activation of PI3K/AKT via RAS–p110 crosstalk
por: Tamaskovic, Rastislav, et al.
Publicado: (2016)

Putative direct and indirect Wnt targets identified through consistent gene expression changes in APC-mutant intestinal adenomas from humans and mice
por: Segditsas, Stefania, et al.
Publicado: (2008)

Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways
por: Janda, Elzbieta, et al.
Publicado: (2002)

Novel zinc-based fixative for high quality DNA, RNA and protein analysis
por: Lykidis, Dimitrios, et al.
Publicado: (2007)

Quantitation of class IA PI3Ks in mice reveals p110-free-p85s and isoform-selective subunit associations and recruitment to receptors
por: Tsolakos, N., et al.
Publicado: (2018)

Delta1 Expression, Cell Cycle Exit, and Commitment to a Specific Secretory Fate Coincide within a Few Hours in the Mouse Intestinal Stem Cell System
por: Stamataki, Despina, et al.
Publicado: (2011)

Myd88 deficiency influences murine tracheal epithelial metaplasia and submucosal gland abundance
por: Giangreco, Adam, et al.
Publicado: (2011)

Activated R-Ras, Rac1, Pi 3-Kinase and Pkcε Can Each Restore Cell Spreading Inhibited by Isolated Integrin β1 Cytoplasmic Domains
por: Berrier, Allison L., et al.
Publicado: (2000)

The E3 ubiquitin ligase Trim7 mediates c-Jun/AP-1 activation by Ras signalling
por: Chakraborty, Atanu, et al.
Publicado: (2015)

Polε Instability Drives Replication Stress, Abnormal Development, and Tumorigenesis
por: Bellelli, Roberto, et al.
Publicado: (2018)

Acetyl-CoA Synthetase 2 Promotes Acetate Utilization and Maintains Cancer Cell Growth under Metabolic Stress
por: Schug, Zachary T., et al.
Publicado: (2015)

PI3Kinase-p110δ Overexpression Impairs Dendritic Morphogenesis and Increases Dendritic Spine Density
por: Hood, Veronica L., et al.
Publicado: (2020)

Genomic Determinants of PI3K Pathway Inhibitor Response in Cancer
por: Weigelt, Britta, et al.
Publicado: (2012)

Regulation of p110δ PI 3-Kinase Gene Expression
por: Kok, Klaartje, et al.
Publicado: (2009)

Unveiling the Mysteries of RAS Signaling: A Journey of Discovery and Breakthroughs
por: Castellano, Esther
Publicado: (2023)

Dominant Role of PI3K p110α over p110β in Insulin and β-Adrenergic Receptor Signalling
por: Zhang, Biqin, et al.
Publicado: (2021)

p110δ PI3 kinase pathway: emerging roles in cancer
por: Tzenaki, Niki, et al.
Publicado: (2013)

Does Ras Activate Raf and PI3K Allosterically?
por: Nussinov, Ruth, et al.
Publicado: (2019)

Tyrosine kinase signalling in breast cancer: Fibroblast growth factors and their receptors
por: Dickson, Clive, et al.
Publicado: (2000)

Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms
por: Lau, H Y, et al.
Publicado: (2017)

Both p110α and p110β isoforms of PI3K can modulate the impact of loss-of-function of the PTEN tumour suppressor
por: Berenjeno, Inma M., et al.
Publicado: (2012)

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer
por: Zhang, Lei, et al.
Publicado: (2020)

RAS oncogenic activity predicts response to chemotherapy and outcome in lung adenocarcinoma
por: East, Philip, et al.
Publicado: (2022)

A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
por: Loboda, Andrey, et al.
Publicado: (2010)

A Case of Intestinal Microsporidiosis in a Renal Transplant Recipient
por: Doshi, Nidhi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6n3tgqetqsllc02p999l40e0ko